186 Use of tolvaptan, a new V2 receptor antagonist, in the...

186 Use of tolvaptan, a new V2 receptor antagonist, in the treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer (SCLC) – a case series

Fraser, I.M., Brooke, A.M., Dorey, N.E., Toy, E.W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(14)70187-4
Date:
January, 2014
File:
PDF, 61 KB
english, 2014
Conversion to is in progress
Conversion to is failed